Short Interest in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Rises By 136.4%

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIBGet Free Report) was the recipient of a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 5,200 shares, an increase of 136.4% from the December 31st total of 2,200 shares. Based on an average daily volume of 10,900 shares, the days-to-cover ratio is currently 0.5 days.

ProShares Ultra Nasdaq Biotechnology Stock Performance

BIB traded up $1.19 on Thursday, hitting $56.01. 6,411 shares of the company were exchanged, compared to its average volume of 8,543. ProShares Ultra Nasdaq Biotechnology has a 12 month low of $47.19 and a 12 month high of $69.56. The stock’s fifty day moving average is $54.20 and its 200-day moving average is $60.49.

ProShares Ultra Nasdaq Biotechnology Increases Dividend

The business also recently announced a dividend, which was paid on Tuesday, December 31st. Stockholders of record on Monday, December 23rd were issued a dividend of $0.3964 per share. This is a positive change from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.15. The ex-dividend date of this dividend was Monday, December 23rd.

Hedge Funds Weigh In On ProShares Ultra Nasdaq Biotechnology

A hedge fund recently raised its stake in ProShares Ultra Nasdaq Biotechnology stock. Jane Street Group LLC increased its position in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIBFree Report) by 8.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,803 shares of the exchange traded fund’s stock after purchasing an additional 374 shares during the period. Jane Street Group LLC owned approximately 0.35% of ProShares Ultra Nasdaq Biotechnology worth $306,000 at the end of the most recent quarter.

ProShares Ultra Nasdaq Biotechnology Company Profile

(Get Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.

Further Reading

Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.